Mylan Inc (NASDAQ:MYL)

During the Trading Day
57.89 +0.56 / +0.99%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
57.00 -0.89 / -1.54%
 
Volume: 86.5K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$21.5B

Company Description

Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. Mylan was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Contact Information

Mylan, Inc.
1500 Corporate Drive
Canonsburg Pennsylvania 15317
P:(724) 514-1800
Investor Relations:

Employees

Shareholders

Other institutional47.06%
Mutual fund holders43.42%
Individual stakeholders2.75%

Top Executives

Heather M. BreschChief Executive Officer & Director
Rajiv MalikPresident & Director
John D. SheehanChief Financial Officer & Executive Vice President
Daniel C. RizzoSenior Vice President & Controller
Joseph F. HaggertySecretary, Senior VP & Global General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account